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Near quantitative yieldsAbstract An efficient nitrosylation of imidazo[1,2-a]pyridines has been developed using tert-Butyl
nitrite (TBN) as the NO resource. The nitrosylation protocol demonstrates broad compatibilities,
with various functional groups such as halogen, Me, OMe, COOMe et al. well tolerated. Near
quantitative yields could be obtained within the imidazo[1,2-a]pyridine scaffold under the optimized
conditions.
 2016 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In recent years, C–H activation has emerged as a powerful strat-
egy for the construction of various small molecules and pharma-
ceutical intermediates. However, the current protocol focused
on the precious metal catalyst, including Pd, Rh, and Ir salts
[1]. Alternatively, earth-abundant first-row transition-metal
such as Fe, Co, and Ni served as potential replacements with
the advancement of synthetic methodology and technology [2].
However, there is still a great need to develop environmentallybenign, operationally convenient and green protocol without
the aid of metal catalysis [3].Meanwhile, imidazo[1,2-a]pyridine
derivatives have been extensively investigated owing to their
pharmaceutical and biological applications [4–6]. Many com-
mercialized drugs containing imidazo[1,2-a]pyridine skeleton
[7,8], such as alpidem, saripidem and zolpidem et al., have been
developed (Fig. 1) [9–15]. The biological activities of imidazo
[1,2-a]pyridine are dependent on different substituents at its
framework. In this context, our group has been interested in
exploring new methodologies with regard to established
imidazo[1,2-a]pyridine derivatives [16–18]. In 2015, we
described a Rh(III)-catalyzed annulation of 2-arylimidazo[1,2-
a]pyridines and alkynes via direct double C–H activation [16].
To avoid the use of catalytic amount of metal catalysis,
catalyst-free Friedel–Crafts hydroxyalkylation [17] and alkyla-
tion [18] of imidazo[1,2-a]pyridine were also reported. Among
the imidazo[1,2-a]pyridine derivants, 3-nitrosoimidazo[1,2-a]-
pyridine complexes have received wide attention for their
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Figure 1 Imidazo[1,2-a]pyridine as the framework in drugs.
Table 1 Screening of the nitrosylation reaction conditions.
N
N catalyst
NO resource, solvent,
Temp.
N
N
NO
1a 3aa
Entrya Catalyst NO
source
Solvent Temp.
[C]
Yield
[%]b
1 Pd
(OAc)2
NaNO2 DCE 90 –
2 RhCl3 NaNO2 DCE 90 –
3 NiCl2 NaNO2 DCE 90 –
4 Pd
(OAc)2
AgNO2 DCE 90 28
5 Pd
(OAc)2
TBN DCE 90 86
6 – TBN DCE 90 99
7c – TBN DCE 90 99
8c – TBN CH3CN 90 87
9c – TBN Acetone 90 79
10c – TBN DMF 90 87
11c – TBN THF 90 89
12c – TBN DME 90 55
13c – TBN Xylene 90 Trace
14c – TBN Ethanol 90 Trace
15c – TBN DCE 25 N.R.
16c – TBN DCE 70 51
17c – TBN DCE 110 99
a Reaction conditions: 1a (0.2 mmol), NO source (0.4 mmol),
catalyst 10 mol%, solvent (1 mL), 2 h.
b Isolated yield.
c 30 min.
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the direct C3 nitrosylation of imidazo[1,2-a]pyridine frame-
works have been reported [20–22], most of them adopted
HNO3 or HNO2 as the NO source. In order to avoid the acidic
and harsh conditions, the development of general and efficient
methods for the nitrosylation of imidazo[1,2-a]pyridine is highly
desirable. Herein, we reported a straightforward and general
route for the synthesis of 3-nitrosoimidazo[1,2-a]pyridines.
2. Methods
2.1. Materials
2-Phenylimidazo[1,2-a]pyridines were prepared according to
previous literature [23]. All other chemicals including Pd
(OAc)2, RhCl3, and NiCl2, as well as NO sources (AgNO2,
NaNO2, and TBN) were used as purchased without purifica-
tion unless otherwise stated. The solvent employed to the reac-
tion was dried and freshly distilled before use.
2.2. Instrumentation
1H and 13C NMR spectra were all recorded on a Bruker DPX
400 instrument using TMS as an internal standard. Data are
reported as follows: chemical shift (d ppm), multiplicity
(s= single, d= doublet, t= triplet, q= quartet, m=multi-
plet), integration, and coupling constants in Hertz (Hz). Melt-
ing points were measured on a WC-1 instrument and were
uncorrected. HRMS was determined on aWaters Q-Tof Micro
MS/MS System ESI spectrometer. Flash column chromatogra-
phy was performed on silica gel (200–300 mesh).
2.3. General procedure for the synthesis of 3-nitroso-2-
phenylimidazo[1,2-a]pyridine
In a 10 mL vial were added the requisite 2-arylimidazo[1,2-a]
pyridine derivatives (1.0 eq.), TBN (2.0 eq.) and DCE
(1 mL). The reaction vial was sealed and heated to 90 C for
30 min. After cooling to room temperature, the product was
isolated through silica gel chromatography using CH2Cl2 as
an eluent to afford the desired product.
3. Results and discussion
Initially, we speculated that the nitrosylation of imidazo[1,2-a]
pyridine at C3 position would require metal as the catalyst via
C–H functionalization. Based on this hypothesis, several metal
catalysts have been applied into the reaction. Pd(OAc)2 was
tested firstly owing to its outstanding catalytic activities in
C–H activation. However, no target product was obtained
under the setting reaction conditions (Table 1, entry 1).
Subsequently, RhCl3 and NiCl2 were also introduced intothe nitrosylation reaction, respectively (Table 1, entry 2–3).
However, there was still no desired product obtained. Using
AgNO2 as the NO source instead of NaNO2 could achieve
slightly better yield (Table 1, entry 4). In view of above unsat-
isfied results, we attempted to explore the reaction in the pres-
ence of other NO source. As the nitrosylation reagent, TBN
has been reported in homogeneous catalytic system to success-
fully access oxindoles and quinoxaline N-oxides [24,25]. We
were interested in investigating TBN initialized nitrosylation
of imidazo[1,2-a]pyridine derivants. To our delight, a moder-
ate yield was achieved using a mixture of palladium salts and
TBN (Table 1, entry 5). Unexpectedly, the yield could reach
up to 99% yield in the absence of metal salts in 2 h (Table 1,
entry 6). The excellent result could be still reproduced in
0.5 h (Table 1, entry 7), indicating that the reaction could
proceed smoothly in the metal free system. With preliminary
data in hand, a variety of solvents were screened. As can be
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Scheme 1 Nitrosylation of imidazo[1,2-a]pyridines derivants.
Nitrosylation of imidazo[1,2-a]pyridines 93seen from Table 1, good yields could be achieved in CH3CN,
acetone, DMF and THF (Table 1, entries 8–11). When
DME was used as the solvent, the yield dropped dramatically
to 55% (Table 1, entry 12). Moreover, the reaction could
hardly be carried out in xylene or ethanol (Table 1, entries
13–14). Using DCE as the chosen solvent, we turned our atten-
tion to the influence of temperature on the nitrosylation reac-
tion. No target product could be detected at room temperature
(Table 1, entry 15). On raising the temperature, the corre-
sponding yields were also increased with 51% yield obtained
at 70 C (Table 1, entry 16). While further increasing the tem-
perature up to 110 C, the reaction could still be accomplished
in excellent yield (Table 1, entry 17).
To investigate the scope of the protocol, various
2-phenylimidazo[1,2-a]pyridine derivatives were employed
under the optimized reaction conditions. Encouragingly, most
2-arylimidazo[1,2-a]pyridines could be efficiently nitrosylated
at the C (3) position (Scheme 1). The corresponding nitrosyla-
tion products were isolated in good or excellent yields.
2-arylimidazo[1,2-a]pyridines bearing electron-donating groups
including Me, OMe, Et, and t-Bu, or electron-withdrawing
groups, such as F, Cl, Br, NO2, COOMe and CF3 were well tol-
erated (Scheme 1). Especially, iodine substituent could still stay
intact during the nitrosylation reaction rather than a cleave
from the imidazo[1,2-a]pyridine rings (Scheme 1, 3bd, 3ge).
Substituents at various positions of the 2-arylimidazo[1,2-a]
pyridines do not affect the yields significantly. The substituent
groups (R1 and R2) could be located at C (6) or C (7) position
of imidazo[1,2-a]pyridine ring, and at ortho-, meta-, or para-position of the phenyl ring. In order to broaden the substrate
varieties, several heterocyclic rings were also investigated and
proved to be applicable for the catalytic protocol.
(Scheme 1, 3ha, 3ia, and 3ja).
4. Conclusions
We have developed an effective method for the nitrosylation of
imidazo[1,2-a]pyridines in metal free system using TBN as the
NO source. Various C-3 nitrosylated imidazo[1,2-a]pyridines
were obtained in good to excellent yields in 30 min. Mean-
while, the generated products could be used as precursors for
multiple transformations. Environmental benignity, functional
group tolerance, high efficiency, and straightforward operation
make this protocol an effective methodology for industrial
applications.
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